top of page
City Cable Car

我们的材料

CIAO 的教育材料由旧金山公共卫生局开发,并由专家小组审核。材料定期更新,涵盖新的科学文献以及政策和项目的变化。

我们的资料旨在供大家使用和分享!如果您有兴趣使用、改编或进一步了解我们的资料,请填写我们的联系表格。

Bup 和 Stim_spreads_9.pdf.png

最后更新:2024年4月

CIAO团队致力于通过推广均衡的护理方法,降低阿片类药物和兴奋剂相关的发病率和死亡率。本指南旨在为希望为吸毒患者提供更高标准护理的医疗保健提供者提供资源。

位于旧金山的供应商可以在此与 CIAO 团队的成员报名参加更深入的一对一教育课程

《阿片类药物与慢性疼痛初级保健指南》封面。封面采用橙色和蓝色背景,并附有医疗服务提供者的图片。

阿片类药物与慢性疼痛:初级保健提供者指南

最后更新:2023年2月

This Guide was created as a resource for primary care providers who may be inheriting patients on opioids or want to provide a higher standard of care for their patients who use drugs.

Providers may also utilize CIAO's Inheriting Patients on Opioids Toolkit here.

The Center for Innovative Academic Detailing on Opioids and Stimulants (CIAO), at the San Francisco Department of Public Health, has prepared online coursework modules with the aim of educating learners on topics related to the management of opioids and chronic pain in the primary care setting as well as how to communicate relevant information to patients and providers.

The knowledge-based curriculum is designed for a wide range of health professionals, including physicians, pharmacists, physician assistants, nurse practitioners, registered nurses, and health educators who care for patients who use opioids, who use illicit substances, or who have chronic pain, in the primary care setting

The curriculum consists of eleven (11) short on-demand courses, which can be completed in any order. A certificate of credit will be issued for each module individually, with an option to print a certificate including all credits earned upon completion of the curriculum. Courses will be released over time, and include:

Currently Available:
1. Naloxone
2. Opioid Use Disorder
3. Buprenorphine
4. Substance Use Disorders
5. Reducing or Stopping Opioids for Chronic Pain 
6. Urine Toxicology
7. Opioid Stewardship

8. Starting Opioids for Chronic Pain

 

Coming Soon:
9. Chronic Pain Management
10. Motivational Interviewing

11. Academic Detailing Basic Skills

This course meets the new Medication Access and Training Expansion (MATE) Act requirements from the Drug Enforcement Administration (DEA) for training on substance use disorders. Please note that not all credit hours are currently available. Providers planning to receive or renew their DEA registration can currently earn 5.75 hours toward their 8-hour MATE requirement. More hours will be added in the near future.

Previous Webinars

The Center for Innovative Academic Detailing on Opioids and Stimulants (CIAO) is continuing­­­­ its quarterly webinar series on topics related to opioid prescribing, opioid stewardship, managing opioid use disorder, and academic detailing on those topics. The webinar will focus on patients prescribed long-term opioids who are abandoned when a clinic shuts down, or when a clinician relocates or loses their license to practice. The webinar will begin with real case studies about the morbidity, mortality, and challenges faced by patients in this situation, and explore resources available to clinicians who are hesitant to take on either inherited or abandoned patients. A mock detailing session will also illustrate how to talk with clinicians about both the perils of abandoning patients on opioids and some best practices in initiating care for an abandoned patient. The information will be presented using CIAO's Toolkit for Inheriting Patients on Long-term Opioids.

Date: May 9th, 2023

View the webinar recording here.

View the webinar slides here.

Find the 1st Vice article here.

Find the 2nd Vice article here.

Find the New York Times article here.

The Center for Innovative Academic Detailing on Opioids and Stimulants (CIAO) is continuing­­­­ its quarterly webinar series on topics related to opioid prescribing, opioid stewardship, managing opioid use disorder, and academic detailing on those topics. This webinar will briefly review the basics of academic detailing skills and concepts, including performing the needs assessment, preparing for possible barriers, communicating key messages, and supporting clinician behavior change. They will then use reference cases and mock detailing sessions to bridge the gap between theory and application. CIAO’s academic detailing training is modeled after evidence-based practices from the National Resource Center for Academic Detailing.

Date: October 25, 2022

View the webinar recording here.

View the webinar slides here.

阿片类药物和兴奋剂创新学术详述中心(CIAO) 将继续举办季度网络研讨会系列,探讨阿片类药物处方、阿片类药物管理、阿片类药物使用障碍管理以及这些主题的学术详述。网络研讨会将回顾尿液药物筛查(UDS),包括 UDS 背后的技术、UDS 结果的解读,以及如何在临床实践中以非惩罚性的方式运用 UDS 来提升患者护理。本研讨会以案例研究的形式,运用 CIAO 的《 阿片类药物和慢性疼痛:初级保健提供者指南》指南进行讲解。

日期:2022年6月28日

在此处查看网络研讨会幻灯片

The Center for Innovative Academic Detailing on Opioids and Stimulants (CIAO) is continuing its quarterly webinar series, CIAO Time, to share evidence-based information related to opioid prescribing, opioid stewardship, and managing opioid use disorder. On February 2, 2022, CIAO staff will discuss the epidemiology of the overdose crisis related to fentanyl and the effect on evidence-based overdose prevention interventions. In particular, CIAO will discuss the impact on naloxone programming and medications for opioid use disorder, including the role of overlap initiation for buprenorphine treatment. This information will be presented using CIAO’s Opioids and Chronic Pain: A Guide for Primary Care Providers guidebook. The presentation will include a live detailing demonstration and an opportunity to ask questions.

Date: February 2, 2022

View the webinar recording here.

View the webinar slides here.

The Center for Innovative Academic Detailing on Opioids and Stimulants (CIAO) is continuing­­­­ its quarterly webinar series on topics related to opioid prescribing, opioid stewardship, and managing opioid use disorder. This webinar will focus on how providers can implement opioid stewardship measures when using these medications in chronic pain management. We will cover assessments, drug screening, controlled substance monitoring programs, naloxone, and—most importantly—documentation. This information will be presented using CIAO’s Opioids and Chronic Pain: A Guide for Primary Care Providers guidebook. The presentation will include a live detailing demonstration and opportunity to ask questions.

Date: October 20, 2021

View the webinar recording here.

View the webinar slides here.

Due to recent closures of 29 LAGS pain management clinics in California, up to 20,000 patients receiving pain management will be seeking alternative care. Some of these patients may be on long-term opioid therapy for chronic pain, a serious challenge for nearby providers. If you have received patient transfer requests or are otherwise affected by these closures, please view the following webinar for information and clinical tools about inheriting patients on opioid therapy, ensuring continuity of care, and utilizing buprenorphine. Affected providers can also register for a one-on-one informational session with CIAO’s clinician trainers to discuss these topics at https://www.ciaosf.org/contact-us.

  

Date: June 23, 2021

View the webinar recording here

View the webinar slides here. 

Resources from the webinar here.

阿片类药物和兴奋剂创新学术细节中心(CIAO) 将继续举办季度网络研讨会系列,探讨阿片类药物处方、阿片类药物管理以及阿片类药物使用障碍管理等主题。本次网络研讨会的主题是慢性疼痛管理,包括回顾非阿片类药物治疗慢性疼痛的方法以及在适当情况下使用阿片类药物治疗疼痛的合理性。这些信息将通过 CIAO 的 《阿片类药物与慢性疼痛:初级保健提供者指南》以案例研究的形式呈现。演讲将包含现场详细演示和提问机会。

  

日期:2021年6月9日

在此处查看网络研讨会录音

在此处查看网络研讨会幻灯片

此次面向加州学术细节专员和项目工作人员的网络研讨会,回顾了CIAO最新更新的学术细节指南《 阿片类药物和慢性疼痛:初级保健提供者指南》 。CIAO 工作人员还演示了模拟电子细节会议,并围绕细节专员和项目工作人员在其诊所或医疗系统中遇到的常见学术细节访问和实施障碍展开了讨论。

日期:2021年5月12日

在此处查看网络研讨会录音

在此处查看网络研讨会幻灯片

阿片类药物和兴奋剂创新学术细节中心(CIAO) 继续举办季度网络研讨会系列,探讨阿片类药物处方、阿片类药物管理以及阿片类药物使用障碍管理等主题。本次网络研讨会的主题是丁丙诺啡,包括丁丙诺啡的作用、临床治疗中使用丁丙诺啡的常见障碍以及丁丙诺啡诱导和维持方案。本信息基于 CIAO 的《 阿片类药物和慢性疼痛:初级保健提供者指南》手册进行讲解。研讨会包含现场细节演示。

日期:2021年3月15日

在此处查看网络研讨会录音

在此处查看演示幻灯片

阿片类药物和兴奋剂创新学术细节中心(CIAO) 启动了其季度网络研讨会系列,主题涉及阿片类药物处方、阿片类药物管理以及阿片类药物使用障碍管理。首场网络研讨会的主题是阿片类药物减量,包括是否减量、何时减量、如何制定“以患者为中心”的计划以及减量机制。这些信息将参考 CIAO 的《 阿片类药物和慢性疼痛:初级保健提供者指南》。研讨会包含现场细节演示。

日期:2020年12月9日

在此处查看网络研讨会录音

在此处查看演示幻灯片

自2022年12月起,联邦政府不再要求执业医师持有X-Waiver(药物滥用豁免)才能开具丁丙诺啡用于治疗阿片类药物使用障碍 (OUD)。现在只需提供标准的DEA注册编号即可。SAMHSA关于这些变化细节的信息可在此处查阅。

bottom of page